In vitro maturation: Clinical applications / 대한생식의학회지
Clinical and Experimental Reproductive Medicine
; : 143-147, 2013.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-34819
Responsible library:
WPRO
ABSTRACT
Oocyte in vitro maturation (IVM) is an assisted reproductive technology in which oocytes are retrieved from the antral follicles of unstimulated or minimally stimulated ovaries. IVM of human oocytes has emerged as a promising procedure. This new technology has advantages over controlled ovarian stimulation such as reduction of costs, simplicity, and elimination of ovarian hyperstimulation syndrome. By elimination or reduction of gonadotropin stimulation, IVM offers eligible infertile couples a safe and convenient form of treatment, and IVM outcomes are currently comparable in safety and efficacy to those of conventional in vitro fertilization. IVM has been applied mainly in patients with polycystic ovary syndrome or ultrasound-only polycystic ovaries, but with time, the indications for IVM have expanded to other uncommon situations such as fertility preservation, as well as to normal responders. In this review, the current clinical experiences with IVM will be described.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Oocytes
/
Ovary
/
Ovulation Induction
/
Polycystic Ovary Syndrome
/
Fertilization in Vitro
/
Family Characteristics
/
Ovarian Hyperstimulation Syndrome
/
Reproductive Techniques, Assisted
/
Fertility Preservation
/
In Vitro Oocyte Maturation Techniques
Limits:
Female
/
Humans
Language:
English
Journal:
Clinical and Experimental Reproductive Medicine
Year:
2013
Document type:
Article